Zacks Investment Research upgraded shares of MEDTOX SCIENTIF (MTOX) from NEUTRAL to OUTPERFORM on May 10, 2012, with a target price of $22.70.
Medtox Scientific sells laboratory testing services in forensic toxicology, clinical toxicology, & heavy metal analyses as well as from mfd. products including a variety of on-site screening products. The Company's customers for abused substance testing include public and private corporations. Among this customer base are Fortune 500 companies. In addition to public and private corporations, abused substance testing is also conducted on behalf of service firms such as financial institutions, drug treatment counseling centers and hospitals.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on MEDTOX SCIENTIF (MTOX),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment